• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Intern Med . Residual pulmonary infiltrates, symptoms and diffusion impairment at one-year after severe COVID-19 infection have different associa

tetano

Editor, Senior Moderator
J Intern Med


. 2023 Apr 10.
doi: 10.1111/joim.13642. Online ahead of print.
Residual pulmonary infiltrates, symptoms and diffusion impairment at one-year after severe COVID-19 infection have different associated factors


Rosario Menéndez[SUP] 1 2 3 4 [/SUP], Raúl Méndez[SUP] 1 2 3 4 [/SUP], Ana Latorre[SUP] 1 2 [/SUP], Paula González-Jiménez[SUP] 1 2 4 [/SUP], Germán Peces-Barba[SUP] 5 [/SUP], María Molina[SUP] 6 [/SUP], Pedro Pablo España[SUP] 7 [/SUP], Estela García[SUP] 8 [/SUP], Angélica Consuegra-Vanegas[SUP] 9 [/SUP], Ana Pando-Sandoval[SUP] 10 [/SUP], Carolina Panadero[SUP] 11 [/SUP], Juan Marco Figueira-Gonçalves[SUP] 12 [/SUP], David De la Rosa[SUP] 13 [/SUP], Oriol Sibila[SUP] 14 [/SUP], María Dolores Martínez-Pitarch[SUP] 15 [/SUP], Nuria Toledo[SUP] 16 [/SUP], Pilar Cejudo[SUP] 17 [/SUP], Wanda Almonte-Batista[SUP] 18 [/SUP], Abigail Macías-Paredes[SUP] 19 [/SUP], Diana Badenes[SUP] 20 [/SUP], Eli Nancy Pérez-Rodas[SUP] 21 [/SUP], Javier Lázaro[SUP] 22 [/SUP], Sarai Quirós[SUP] 23 [/SUP], Rosa Cordovilla[SUP] 24 [/SUP], Irene Cano-Pumarega[SUP] 3 25 [/SUP], Antoni Torres[SUP] 14 [/SUP]



Affiliations

Abstract

Introduction: After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia, patients may show lung sequelae on radiology and functional impairment at the 1-year follow-up. We aimed to describe the persistence of symptoms, radiological alterations, or reduced diffusing capacity of the lung for carbon monoxide (D[SUB]LCO[/SUB] ) at 1-year follow-up in patients from the Spanish Registry RECOVID.
Methods: RECOVID collected symptom and radiological and functional lung tests data on hospitalised patients with coronavirus disease 2019 during the acute phase and at the 6- and 12-month follow-up visits.
Results: Of the 2500 enrolled survivors (90% admitted to the ward), 1874 had follow-up visits for up to a year. Of these, 42% continued to present with symptoms, 27% had radiological sequelae, and 31% had reduced D[SUB]LCO[/SUB] . Independently associated factors included female sex, asthma, and the requirement for invasive or non-invasive mechanical ventilation. Complete radiological resolution was 72.2% at 12 months; associated factors with incomplete recovery were age, male sex, oxygen or respiratory support, corticosteroids and an initial SpO[SUB]2[/SUB] /FiO[SUB]2[/SUB] <450 or CURB65 ≥2. Reduced D[SUB]LCO[/SUB] was observed in 31% of patients at 12 months; associated factors were older age, female sex, smoking habit, SpO[SUB]2[/SUB] /FiO[SUB]2[/SUB] <450 and CURB-65 ≥2, and the requirement of respiratory support. At 12 months, a proportion of the asymptomatic patients showed reduced D[SUB]LCO[/SUB] (9.5%), radiological findings (25%), or both (11%).
Conclusions: The factors associated with symptom persistence, incomplete radiological resolution, and D[SUB]LCO[/SUB] <80% differed according to age, sex, comorbidities, and respiratory support. The burden of symptoms, reduced D[SUB]LCO[/SUB] , and incomplete radiological resolution were considerable in patients with SARS-CoV-2 pneumonia at the 1-year follow-up after hospitalisation. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; RECOVID; SARS-CoV-2; SEPAR.
 
Back
Top Bottom